← All tickers

Is CRMD Worth Buying in 2026?

CorMedix Inc.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-16

Here’s whether CorMedix Inc. (CRMD) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Positives: RSI 49 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-1.78% over 10 days); weak 1-year return of -40.2%; rising volume on a downtrend (distribution, 1.38x avg). Currently 49.6% off its 52-week high. Score: -4/7.

Ready to act on this? 📈 Trade on Webull

CRMD is trading below its 200-day MA ($8.47) — a key warning sign the longer-term trend is under pressure. An RSI of 49.1 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -40.2% compares to +20.4% for SPY (trailed the market by 60.6%). The current 49.6% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $5,979 today
vs. S&P 500 (SPY) — same period trailed market by 60.6%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✗Above 200-day MA ($8.47)
✗Above 50-day MA ($8.13)
✓RSI(14) neutral zone (30–70) — currently 49.1
✗Positive return (-40.2%)
!Within 10% of period high (−49.6%)
Period Range $7.54
$6.13 $14.96
RSI (14) 49.1
0 · OversoldOverbought · 100

Key Metrics

Price$7.54
Period Return-40.2%
Period High$14.96
Period Low$6.13
Drawdown−49.6%
MA-50$8.13
MA-200$8.47
RSI (14)49.1
Avg Volume (30d)1.1M
vs. SPYtrailed by 60.6%
Return Rank#1015 of 1252

Trade CRMD

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers